Edwards Lifesciences (EW) Operating Income Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) Operating Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 74.18% |
| 10 | Steris | 21.54 Bn | 21.10 Bn | 697.10 Mn | 46.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.97% |
| Dec 31, 2025 | -51.66% |
| Sep 30, 2025 | -12.41% |
| Jun 30, 2025 | 12.20% |
| Mar 31, 2025 | 13.12% |
| Dec 31, 2024 | -9.86% |
| Sep 30, 2024 | -4.18% |
| Jun 30, 2024 | 39.09% |
| Mar 31, 2024 | -10.14% |
| Dec 31, 2023 | 75.42% |
| Sep 30, 2023 | -9.07% |
| Jun 30, 2023 | -42.66% |
| Mar 31, 2023 | -11.49% |
| Dec 31, 2022 | -47.20% |
| Sep 30, 2022 | 3.10% |
| Jun 30, 2022 | -15.24% |
| Mar 31, 2022 | 14.42% |
| Dec 31, 2021 | 6.55% |
| Sep 30, 2021 | 9.08% |
| Jun 30, 2021 | 419.45% |